Kalina L. Tosheva

Kalina L. Tosheva

Auto-generated profile, based on publicly available information

Kalina L. Tosheva

Molecular Mechanisms of DNA Repair Laboratory, Institute of Molecular Biology, Bulgarian Academy of Sciences, Acad. G. Bonchev Str. Bl.21, 1113 Sofia, Bulgaria

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2020 in Journal of Physics D: Applied Physics
Verified
Journal Article
Open access
PDF file
KTKalina L. Tosheva
Kalina L. Tosheva
Yue YuanYue Yuan
Yue Yuan
PPPedro Pereira
Pedro Pereira
SCSiân Culley
Siân Culley
Ricardo HenriquesRicardo Henriques
Ricardo Henriques
Super-resolution microscopy (SRM) enables non-invasive, molecule-specific imaging of the internal structure and dynamics of cells with sub-diffraction limit spatial resolution. One of its major limitations is the requirement for high-intensity illumination, generating considerable cellular phototoxicity. This factor considerably limits the capacity for live-cell observations, particularly for extended periods of time. Here, we give an overview of new developments in hardware, software and probe chemistry aiming to reduce phototoxicity. Additionally, we discuss how the choice of biological model and sample environment impacts the capacity for live-cell observations.

25 August 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
PKPetar-Bogomil Kanev
Petar-Bogomil Kanev
VMVanya Milanova
Vanya Milanova
PBPreslava Berkova
Preslava Berkova
DKDimitar Kutrovski
Dimitar Kutrovski
KTKalina Tosheva
Kalina Tosheva
RARadoslav Aleksandrov
Radoslav Aleksandrov
Summary: PARG, the primary enzyme responsible for the reversal of PARP1-mediated poly(ADP-ribosyl)ation, has attracted considerable attention as a therapeutic target in cancer. Yet, the mechanisms underlying PARG inhibitor (PARGi) efficacy remain elusive. Herein, we demonstrate that PARGi prolongs PARP1 residence at damaged chromatin in a manner mechanistically distinct from PARP-inhibitor-induced trapping. That is, PARGi triggers the formation of PAR-driven, FUS-enriched PARP1 nuclear condensates upon DNA damage. Importantly, unrestrained S-phase PARylation during Okazaki fragment maturation also elicited PARP1 condensation in a manner directly reflecting intrinsic PARGi sensitivity, with FEN1 co-inhibition enhancing both PARP1 condensate formation and cytotoxicity. Finally, we discover that dePARylation prevents the rapid nuclear extrusion of PARP1 upon S-phase entry, a phenomenon that is reversible and could undermine PARP1-dependent nuclear processes. Together, our findings reveal that dePARylation precludes the replication-driven condensation of PARP1 and identify Okazaki fragment maturation as a targetable vulnerability that exacerbates condensation and PARGi cytotoxicity.